Fennec Pharmaceuticals Inc.

FRX.TOTSXHealthcare● Active

$12.44

$-0.28(-2.20%)

Market Cap$355535511

P/E Ratio—

52W High$14.24

52W Low$7.59

Avg Volume1K

Open$12.44

Beta1.08

Net Income Financials Revenue

Fennec Pharmaceuticals Inc. (FRX.TO) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

FRX.TO · net income · updated Jun 8, 2026

Core profitability metrics

FRX.TO · net income · margin · TTM · CAGR

Net income was −$10.3M for FY2025 (fiscal year ending 2025-12-31), down 2256.6% year-over-year. Net profit margin was -22.6%. Based on available data, Fennec Pharmaceuticals Inc. has been profitable since at least 2011.

FY2025 Net Income−$10.3M▼ -2256.6% YoY

Trailing 12M (TTM)−$8.8Mtrailing 4 quarters sum

Net Profit Margin-22.6%−$10.3M ÷ $45.4M

YoY Change-2256.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · FRX.TO net income history · FRX.TO profit margin

Annual net income data

FRX.TO · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$10.3M▼ 2256.6%-22.6%$45.4M

FY2024Loss−$436,000▲ +97.3%-0.9%$47.5M

FY2023Loss−$16.0M▲ +32.8%-75.5%$21.3M

FY2022Loss−$23.9M▼ 36.7%-1554.5%$1.5M

FY2021Loss−$17.5M▲ +3.6%—$0

Net income vs peers (Healthcare)

FRX.TO vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Fennec Pharmaceuticals Inc.YOU

FRX.TO

−$10.3M-2256.6%-22.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Fennec Pharmaceuticals Inc. (FRX.TO) reported net income of −$10.3M for FY2025 (fiscal year ending 2025-12-31), down 2256.6% year-over-year. The net profit margin was -22.6% — meaning the company kept $-0.23 of every dollar of revenue as profit.

Based on available data, Fennec Pharmaceuticals Inc. has been profitable since at least 2011. Net income reached a peak of $4.7M in FY2011. Data available for 15 fiscal years.

Fennec Pharmaceuticals Inc.'s net profit margin was -22.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Fennec Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from FRX.TO net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

FRX.TO net income · 4 questions

Fennec Pharmaceuticals Inc. is not currently profitable on an annual basis. The company reported a net loss of $10.3M for FY2025.

is FRX.TO profitabledoes FRX.TO make a profitFRX.TO profitabilityFRX.TO profitable company

▸ Source: FMP /income-statement · GAAP · Fennec Pharmaceuticals Inc. · Fennec Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026